Intimation of Schedule of 'Value Discovery Summit', under the SEBI (Listing Obligations and Disclosure Requirement), Regulation 2015.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fredun Pharmaceuticals has informed the stock exchanges that its management will participate in the 'Beyond the Numbers – Value Discovery Summit 2025', a virtual group meeting with investors and analysts. The event is scheduled for December 16, 2025, at 11:30 A.M. IST. The company has clarified that discussions will be limited to publicly available information and no unpublished price-sensitive information (UPSI) will be shared. The intimation has been filed under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements, 2015, signed by Managing Director Fredun Medhora (DIN: 01745348). This is a routine corporate disclosure to comply with listing regulations ahead of the investor interaction.
This is a standard regulatory disclosure with no direct impact on the stock price or business. It simply informs shareholders about an upcoming investor/analyst interaction and ensures compliance with SEBI listing norms.